Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.
Daria S KostyuninaPaul McLoughlinPublished in: Antioxidants (Basel, Switzerland) (2021)
Pulmonary hypertension (PH) is a condition characterised by an abnormal elevation of pulmonary artery pressure caused by an increased pulmonary vascular resistance, frequently leading to right ventricular failure and reduced survival. Marked sexual dimorphism is observed in patients with pulmonary arterial hypertension, a form of pulmonary hypertension with a particularly severe clinical course. The incidence in females is 2-4 times greater than in males, although the disease is less severe in females. We review the contribution of the sex chromosomes to this sex dimorphism highlighting the impact of proteins, microRNAs and long non-coding RNAs encoded on the X and Y chromosomes. These genes are centrally involved in the cellular pathways that cause increased pulmonary vascular resistance including the production of reactive oxygen species, altered metabolism, apoptosis, inflammation, vasoconstriction and vascular remodelling. The interaction with genetic mutations on autosomal genes that cause heritable pulmonary arterial hypertension such as bone morphogenetic protein 2 (BMPR2) are examined. The mechanisms that can lead to differences in the expression of genes located on the X chromosomes between females and males are also reviewed. A better understanding of the mechanisms of sex dimorphism in this disease will contribute to the development of more effective therapies for both women and men.
Keyphrases
- pulmonary hypertension
- pulmonary arterial hypertension
- pulmonary artery
- genome wide
- long non coding rna
- poor prognosis
- reactive oxygen species
- oxidative stress
- early onset
- risk factors
- endoplasmic reticulum stress
- adipose tissue
- cell proliferation
- cell death
- coronary artery
- type diabetes
- transcription factor
- dna methylation
- pregnant women
- signaling pathway
- middle aged
- skeletal muscle
- cell cycle arrest
- free survival
- cervical cancer screening